申请人:Bayrakdarian Malken
公开号:US20070161643A1
公开(公告)日:2007-07-12
There is provided a compound of formula I
wherein the dashed line, R
1
, R
2
, R
3a
, R
3b
, A, D, E, G and L have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is beneficial (e.g. conditions, such as thrombo-embolisms, where inhibition of thrombin is required or desired, and/or conditions where anticoagulant therapy is indicated).
提供了一种I式化合物,其中虚线,R1,R2,R3a,R3b,A,D,E,G和L的含义在说明书中给出,这些化合物可用作竞争性蛋白酶抑制剂,例如凝血酶,或可用作其前药,因此特别适用于治疗需要抑制凝血酶的情况(例如需要或期望抑制凝血酶的血栓栓塞等疾病,以及需要抗凝治疗的情况)。